Table 1 Summary of signalment, clinical data and evolution for veterinary patients
From: Safety and efficacy of the mesenchymal stem cell in feline eosinophilic keratitis treatment
Parameter | Cat-1 | Cat-2 | Cat-3 | Cat-4 | Cat-5 |
|---|---|---|---|---|---|
Age (years) | 4 | 4 | 5 | 6 | 3 |
Sex | MC | MC | MC | FS | FS |
Breed | DSH | DSH | DSH | DSH | DSH |
Weight (kg) | 3.2 | 3.8 | 3.8 | 4 | 4.1 |
Duration (months) | 12 | 9 | 8 | 10 | 6 |
Eye | R | L | L | R | R |
Lesion localization | ST | ST | IN | IN | ST |
FHV-1 | – | + | + | + | + |
Clinical signs | PL,V, H | PL, V, ED, H | PL, V, ED, H | PL, V, H | PL, V, H |
STT | 14 | 18 | 16 | 21 | 19 |
Cytology | E, M | E, M | E, M, N | E, M | E, M |
Previous treatment | C, Ca, Ao | Ca, Ly, Ao | Ca, C, Ly, Ao | Ca, C, Ly, IΩ, Ao | Ca, Ly, IΩ, Mg, Ao |
Clinical remission | 2 months | 2 months | 6 months | 4 months | 5 months |
Hematologic changes | No | No | No | No | No |